351 related articles for article (PubMed ID: 19741643)
1. Genome-wide identification of post-translational modulators of transcription factor activity in human B cells.
Wang K; Saito M; Bisikirska BC; Alvarez MJ; Lim WK; Rajbhandari P; Shen Q; Nemenman I; Basso K; Margolin AA; Klein U; Dalla-Favera R; Califano A
Nat Biotechnol; 2009 Sep; 27(9):829-39. PubMed ID: 19741643
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional deregulation of oncogenic myocyte enhancer factor 2C in T-cell acute lymphoblastic leukemia.
Nagel S; Venturini L; Meyer C; Kaufmann M; Scherr M; Drexler HG; Macleod RA
Leuk Lymphoma; 2011 Feb; 52(2):290-7. PubMed ID: 21261500
[TBL] [Abstract][Full Text] [Related]
3. Genome-wide dissection of posttranscriptional and posttranslational interactions.
Bansal M; Califano A
Methods Mol Biol; 2012; 786():131-49. PubMed ID: 21938624
[TBL] [Abstract][Full Text] [Related]
4. Association with class IIa histone deacetylases upregulates the sumoylation of MEF2 transcription factors.
Grégoire S; Yang XJ
Mol Cell Biol; 2005 Mar; 25(6):2273-87. PubMed ID: 15743823
[TBL] [Abstract][Full Text] [Related]
5. Dissecting the interface between signaling and transcriptional regulation in human B cells.
Wang K; Alvarez MJ; Bisikirska BC; Linding R; Basso K; Dalla Favera R; Califano A
Pac Symp Biocomput; 2009; ():264-75. PubMed ID: 19209707
[TBL] [Abstract][Full Text] [Related]
6. A new statistical model to select target sequences bound by transcription factors.
Pape UJ; Grossmann S; Hammer S; Sperling S; Vingron M
Genome Inform; 2006; 17(1):134-40. PubMed ID: 17503363
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional mechanisms by the coregulator MAML1.
Saint Just Ribeiro M; Wallberg AE
Curr Protein Pept Sci; 2009 Dec; 10(6):570-6. PubMed ID: 19751190
[TBL] [Abstract][Full Text] [Related]
8. Cisplatin-induced synthetic lethality to arginine-starvation therapy by transcriptional suppression of ASS1 is regulated by DEC1, HIF-1α, and c-Myc transcription network and is independent of ASS1 promoter DNA methylation.
Long Y; Tsai WB; Chang JT; Estecio M; Wangpaichitr M; Savaraj N; Feun LG; Chen HH; Kuo MT
Oncotarget; 2016 Dec; 7(50):82658-82670. PubMed ID: 27765932
[TBL] [Abstract][Full Text] [Related]
9. ZEB1 and c-Jun levels contribute to the establishment of highly lytic Epstein-Barr virus infection in gastric AGS cells.
Feng WH; Kraus RJ; Dickerson SJ; Lim HJ; Jones RJ; Yu X; Mertz JE; Kenney SC
J Virol; 2007 Sep; 81(18):10113-22. PubMed ID: 17626078
[TBL] [Abstract][Full Text] [Related]
10. Dephosphorylation and caspase processing generate distinct nuclear pools of histone deacetylase 4.
Paroni G; Fontanini A; Cernotta N; Foti C; Gupta MP; Yang XJ; Fasino D; Brancolini C
Mol Cell Biol; 2007 Oct; 27(19):6718-32. PubMed ID: 17636017
[TBL] [Abstract][Full Text] [Related]
11. A reverse-engineering approach to dissect post-translational modulators of transcription factor's activity from transcriptional data.
Gambardella G; Peluso I; Montefusco S; Bansal M; Medina DL; Lawrence N; di Bernardo D
BMC Bioinformatics; 2015 Sep; 16():279. PubMed ID: 26334955
[TBL] [Abstract][Full Text] [Related]
12. Casein kinase II increases the transcriptional activities of MRF4 and MyoD independently of their direct phosphorylation.
Johnson SE; Wang X; Hardy S; Taparowsky EJ; Konieczny SF
Mol Cell Biol; 1996 Apr; 16(4):1604-13. PubMed ID: 8657135
[TBL] [Abstract][Full Text] [Related]
13. The Notch effector Hey1 associates with myogenic target genes to repress myogenesis.
Buas MF; Kabak S; Kadesch T
J Biol Chem; 2010 Jan; 285(2):1249-58. PubMed ID: 19917614
[TBL] [Abstract][Full Text] [Related]
14. Molecular mechanisms of myogenic coactivation by p300: direct interaction with the activation domain of MyoD and with the MADS box of MEF2C.
Sartorelli V; Huang J; Hamamori Y; Kedes L
Mol Cell Biol; 1997 Feb; 17(2):1010-26. PubMed ID: 9001254
[TBL] [Abstract][Full Text] [Related]
15. STK38 is a critical upstream regulator of MYC's oncogenic activity in human B-cell lymphoma.
Bisikirska BC; Adam SJ; Alvarez MJ; Rajbhandari P; Cox R; Lefebvre C; Wang K; Rieckhof GE; Felsher DW; Califano A
Oncogene; 2013 Nov; 32(45):5283-91. PubMed ID: 23178486
[TBL] [Abstract][Full Text] [Related]
16. A dynamic exchange of TCF3 and TCF4 transcription factors controls MYC expression in colorectal cancer cells.
Shah M; Rennoll SA; Raup-Konsavage WM; Yochum GS
Cell Cycle; 2015; 14(3):323-32. PubMed ID: 25659031
[TBL] [Abstract][Full Text] [Related]
17. Combinatorial control of muscle development by basic helix-loop-helix and MADS-box transcription factors.
Molkentin JD; Olson EN
Proc Natl Acad Sci U S A; 1996 Sep; 93(18):9366-73. PubMed ID: 8790335
[TBL] [Abstract][Full Text] [Related]
18. Ribosomal Biogenesis and Translational Flux Inhibition by the Selective Inhibitor of Nuclear Export (SINE) XPO1 Antagonist KPT-185.
Tabe Y; Kojima K; Yamamoto S; Sekihara K; Matsushita H; Davis RE; Wang Z; Ma W; Ishizawa J; Kazuno S; Kauffman M; Shacham S; Fujimura T; Ueno T; Miida T; Andreeff M
PLoS One; 2015; 10(9):e0137210. PubMed ID: 26340096
[TBL] [Abstract][Full Text] [Related]
19. Stat3 and c-Myc genome-wide promoter occupancy in embryonic stem cells.
Kidder BL; Yang J; Palmer S
PLoS One; 2008; 3(12):e3932. PubMed ID: 19079543
[TBL] [Abstract][Full Text] [Related]
20. Post-translational control of the MEF2A transcriptional regulatory protein.
Ornatsky OI; Cox DM; Tangirala P; Andreucci JJ; Quinn ZA; Wrana JL; Prywes R; Yu YT; McDermott JC
Nucleic Acids Res; 1999 Jul; 27(13):2646-54. PubMed ID: 10373581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
